Our data suggest that QN-302-mediated stabilization of G4s within the promoter of MDM2 represents an intriguing approach to interfere with the MDM2-p53 pathway in WD/DDLPS for therapeutic purposes as well as in other MDM2-amplified cancers [46, 51, 52]. Here, TP53 is linked to cancer.